Master
Heading
2025 News
Content
- Researchers develop new equations to better calculate children's caloric needs
- Press Release: Endocrine Society
Obesity and type 2 diabetes in teen years can impair bone health - Welcome new team member!
Sara Vivatson, D.O., Post-Doctoral Fellow, joins the lab
Heading
2024 News
Media Component
Content
- Launch of the DISCOVERY study!
This large NIH funded study aims to identify risk factors for youth-onset type 2 diabetes to improve prevention and treatment. To find out more, please visit: DISCOVERY of Risk Factors For Type 2 Diabetes In Youth | BCM - Select New Publications:
- Puyau M, Shypailo R, Butte NF, Musaad S, Bacha F. Prediction models of basal energy expenditure in children and adolescents across the BMI spectrum based on room calorimetry: a cross-sectional cohort study. Am J Clin Nutr. 2025 Feb;121(2):284-292. doi: 10.1016/j.ajcnut.2024.12.003. Epub 2024 Dec 7. PMID: 39653177.
- Bacha F, et al. Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth.
Diabetes Care 2024. PMID: 39250166 - Bacha F, et al. Distinct Amino Acid Profile Characterizes Youth With or at Risk for Type 2 Diabetes. Diabetes 2024. PMID: 38215171
- From Obesity to Strong Bones: Essential Tips for Healthy Kids
ARS-funded research at the Children's Nutrition Research Center in Houston, Texas, delves into the critical connection between childhood obesity and bone health. The research uncovers how excess weight in Hispanic children can negatively affect bone density and mineral content, potentially increasing the risk of fractures. Researchers emphasize the importance of physical activity as a protective measure against these adverse effects and discuss practical strategies for parents to prevent obesity from the outset. Video link (USDA YouTube channel)
Content
2023 News
- Dr. Bacha received an NIH-NIDDK-U01 grant award for the project entitled: “Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes- Texas Children’s Center”.
- Dr. Bacha invited to serve as Diabetes Care Editorial Board Member 2023-2026 (S. Kahn, MB, ChB, Editor).
- Dr. Bacha presents on “Advanced glycation endproducts (AGEs), oxidation products (OPs) and the soluble receptor for AGE (sRAGE) in youth with type 2 diabetes”. National TODAY Study Group Webinar Meeting. January 13, 2023.
2022 News
- Dr. Bacha received grant funding from NICHD for her project entitled: Type 2 Diabetes and Bone Health in Youth
- Dr. Bacha participated as an Invited Delegation Member from Texas Children’s Hospital, Baylor College of Medicine, to the Texas Medical Center-Denmark BioBridge Delegation. Copenhagen, Denmark. September 26-28, 2022 (weblink)
- Dr. Bacha presents: Pediatric Research Programs in Prevention of Chronic Disease. Institutional presentation at the South Goes North Texas Medical Center-Denmark Biobridge Event. September 27, 2022. Copenhagen, Denmark.
- Dr. Bacha invited to join the editorial board of the Journal of Clinical Endocrinology and Metabolism Case Reports 2022-2023 (W.F. Young, MD, Editor)
- Dr. Bacha. Invited Speaker at the Endocrine Society Meeting ENDO 2022: Prevention of Cardiovascular Disease among Young Adults. In Session entitled: Racial and Ethnic Disparities in Adolescent Healthcare. June 11-14, 2022. Atlanta, Georgia, USA.
- Dr. Bacha. Invited Speaker at the American Diabetes Association's 82nd Scientific Sessions: Role and Management of Insulin Resistance and Obesity in Type 2 Diabetes. June 5, 2022. New Orleans, LA.
- Dr. Bacha serves as an Invited Member of the American Diabetes Association Youth Strategies Committee. 2021-2022
- Dr. Bacha serves on the editorial board of Diabetes Care (M. Riddle, MD, Editor; Impact factor 19).
- Dr. Bacha receives the Annual Faculty Educational Award for Excellence in Teaching Baylor Residents in Pediatric Endocrinology, Baylor College of Medicine, June 2022
- Dr Bacha received an award from NIH/NIDDK (5U01DK061230-16) for her project entitled: Advanced glycation endproducts (AGEs) and oxidation products (OPs) and the soluble receptor for AGE (sRAGE): cardiovascular disease risk biomarkers in youth with type 2 diabetes.
Heading
